Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)
Japan · Delayed Price · Currency is JPY 5,490.00
-2.00 (-0.04%)
Feb 13, 2026, 2:44 PM JST
Kobayashi Pharmaceutical Revenue
In the year 2025, Kobayashi Pharmaceutical had annual revenue of 165.74B JPY with 0.09% growth. Kobayashi Pharmaceutical had revenue of 53.70B in the quarter ending December 31, 2025, with 5.01% growth.
Revenue
165.74B
Revenue Growth
+0.09%
P/S Ratio
2.46
Revenue / Employee
45.85M
Employees
3,615
Market Cap
408.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 165.74B | 142.00M | 0.09% |
| Dec 31, 2024 | 165.60B | -7.86B | -4.53% |
| Dec 31, 2023 | 173.46B | 7.20B | 4.33% |
| Dec 31, 2022 | 166.26B | 11.01B | 7.09% |
| Dec 31, 2021 | 155.25B | 4.74B | 3.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paltac | 1.23T |
| Shiseido Company | 969.99B |
| Lion Corporation | 416.73B |
| Rohto Pharmaceutical | 333.80B |
| KOSE Holdings | 324.54B |
| Earth | 177.37B |
| Pola Orbis Holdings | 169.97B |
| Pigeon | 108.66B |